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A B S T R A C T
Polymorphic ventricular tachycardia in the form of torsade des pointes occurred in 
a patient on chronic therapy with amiodarone and a baseline prolonged QT interval, 
only when ciprofloxacin was added for treatment of urinary tract infection and did not 
recur after discontinuation of the antibiotic.
An 87-year-old patient was hospitalized for respiratory insufficiency and diastolic 
heart failure. The patient was on chronic amiodarone therapy for paroxysmal atrial 
fibrillation and had a baseline prolonged QT interval at 600 ms, but had no prior his-
tory of ventricular tachyarrhythmias. He had chronic renal failure with a creatinine 
at 2.2 mg/dl. While in the intensive care unit, the patient developed a urinary tract 
infection for which he was placed on intravenous ciprofloxacin, 400 mg bid. The next 
day the patient sustained an episode of cardiac arrest due to polymorphic ventricular 
tachycardia in the form of typical torsade des pointes (Figure, upper panel), leading 
to immediate collapse of oximetry (mid panel) and blood pressure (lower panel), for 
which he required electrical cardioversion. Electrolytes were checked and found to 
be within normal limits. There was no evidence of acute ischemia. The antibiotic was 
discontinued and there was no further recurrence of ventricular tachyarrhythmias.
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Quinolones are broad-spectrum antibiotic agents com-
monly prescribed for respiratory or urinary tract infections. 
However, they are associated with the possible proarrhyth-
mic side-effect of QT prolongation causing concern with 
regards to the development of life-threatening ventricular 
tachyarrhythmias in the form of polymorphic VT (torsade des 
pointes) leading to cardiac arrest. Among other quinolones, 
ciprofloxacin often is chosen because of its perceived weaker 
proarrhythmic potential conferring lower rates of torsade des 
pointes compared with the other compounds of this class of 
antibiotics. However, as shown in the present case and a few 
other reports in the literature,1-3 it also possesses a cardiotoxic 
effect and can lead to serious proarrhythmia by causing tor-
sade des pointes. This is particularly noted in the presence of 
other concomitant risk factors, among which one should in-
clude chronic amiodarone therapy which consistently prolongs 
the QT interval, albeit rarely does it by itself cause torsades 
des pointes compared with other antiarrhythmic agents (e.g., 
quinidine or sotalol). Thus, in patients with a baseline pro-
longed QT interval, other potentially QT-prolonging agents 
should best be entirely avoided.
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